Home / KLK10 Knockout Cell Lines

KLK10 Knockout Cell Lines

Gene: KLK10

Official Full Name: kallikrein related peptidase 10provided by HGNC

Gene Summary: Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO35868 KLK10 Knockout cell line (HCT 116) Human KLK10 1:2~1:4 Negative Online Inquiry

Background

KLK10 Gene Knockout Cell Lines represent a significant advancement in cellular biology, specifically designed for in-depth studies of the Kallikrein-Related Peptidase 10 (KLK10) gene. This product involves the precise ablation of the KLK10 gene through CRISPR/Cas9 gene-editing technology, enabling researchers to explore the gene's functional roles in various biological processes, including cancer progression, inflammation, and tissue homeostasis.

The primary function of KLK10 Gene Knockout Cell Lines is to serve as a platform for elucidating the molecular mechanisms underlying KLK10 contributions to pathological conditions. By completely knocking out the KLK10 gene, these cell lines facilitate investigations into the resultant phenotypic changes, signaling pathways, and gene expression profiles. This comprehensive approach assists in identifying potential therapeutic targets and biomarkers associated with diseases.

The scientific significance of KLK10 Gene Knockout Cell Lines lies in their applications across a range of research and clinical settings. Researchers can utilize these cell lines for drug discovery, mechanistic studies, and validation of KLK10 as a target for therapeutic intervention. Moreover, in clinical research, understanding KLK10's role could unravel crucial insights into its involvement in diseases such as breast cancer and other malignancies, paving the way for novel treatment strategies.

One of the standout advantages of our KLK10 Gene Knockout Cell Lines is their reliability and reproducibility compared to conventional methods, which may produce variable knockout efficiencies. Our proprietary cell lines are validated for consistent genetic alteration and maintained under optimal conditions, ensuring that researchers receive accurate and trustworthy data. Additionally, our comprehensive technical support enhances the user experience, allowing researchers to focus on their experiments without being stymied by technical challenges.

Incorporating KLK10 Gene Knockout Cell Lines into your research arsenal adds immense value, yielding insights that could lead to groundbreaking therapeutic discoveries. As experts in the field of biological products, our company is committed to providing high-quality, innovative solutions that empower researchers and clinicians to advance their scientific inquiries and improve patient outcomes.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.